Empagliflozin Alleviates Hepatic Steatosis by Activating the AMPK-TET2-Autophagy Pathway in vivo and in vitro

Background: Metabolic associated fatty liver disease (MAFLD), characterized by hepatic lipid accumulation and fatty degeneration, is intertwined with obesity and type 2 diabetes mellitus (T2DM). Empagliflozin is a sodium-glucose cotransporter-2 inhibitor that effectively lowers blood glucose, but it...

Full description

Saved in:
Bibliographic Details
Main Authors: Ting Li (Author), Ting Fang (Author), Linxin Xu (Author), Xiangyang Liu (Author), Xiaoyu Li (Author), Mei Xue (Author), Xiaochen Yu (Author), Bei Sun (Author), Liming Chen (Author)
Format: Book
Published: Frontiers Media S.A., 2021-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available